Tan DS - Search Results

1

Incidence of thromboembolic and bleeding events in patients with newly diagnosed nonvalvular atrial fibrillation: An Asian multicenter retrospective cohort study in Singapore.

Wee XT, Ho LM, Ho HK, Lee JY, Yap CW, William H, Chan LCE, Tay HC, Goh CEM, Tan DS. Wee XT, et al. Among authors: tan ds. Clin Cardiol. 2017 Dec;40(12):1218-1226. doi: 10.1002/clc.22811. Epub 2017 Dec 18. Clin Cardiol. 2017. PMID: 29251769 Free PMC article.

2

Prevalence of dysglycaemic events among inpatients with diabetes mellitus: a Singaporean perspective.

Ong KY, Kwan YH, Tay HC, Tan DS, Chang JY. Ong KY, et al. Among authors: tan ds. Singapore Med J. 2015 Jul;56(7):393-400. doi: 10.11622/smedj.2015110. Singapore Med J. 2015. PMID: 26243976 Free PMC article.

3

Identifying Potentially Avoidable Readmissions: A Medication-Based 15-Day Readmission Risk Stratification Algorithm.

Dorajoo SR, See V, Chan CT, Tan JZ, Tan DS, Abdul Razak SM, Ong TT, Koomanan N, Yap CW, Chan A. Dorajoo SR, et al. Among authors: tan jz, tan ds. Pharmacotherapy. 2017 Mar;37(3):268-277. doi: 10.1002/phar.1896. Epub 2017 Feb 20. Pharmacotherapy. 2017. PMID: 28052412

4

Drug Class, Renal Elimination, and Outcomes of Direct Oral Anticoagulants in Asian Patients: A Meta-Analysis.

Wang KL, Chiu CC, Giugliano RP, Tan DS, Lin CY, Lai EY, Goto S, Chiang CE. Wang KL, et al. Among authors: tan ds. J Stroke Cerebrovasc Dis. 2018 Apr;27(4):857-864. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.027. Epub 2017 Nov 26. J Stroke Cerebrovasc Dis. 2018. PMID: 29239808 Review.

5

Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.

Wang KL, Lopes RD, Patel MR, Büller HR, Tan DS, Chiang CE, Giugliano RP. Wang KL, et al. Among authors: tan ds. Eur Heart J. 2019 May 14;40(19):1492-1500. doi: 10.1093/eurheartj/ehy802. Eur Heart J. 2019. PMID: 30590440

6

CYP2C19 phenotype in South-East Asian Acute Coronary Syndrome patients and impact on major adverse cardiovascular events.

Tan DS, Aw JWX, Winther M, Goh LL, Ong HY, Wee E, Liu J, Ho HK. Tan DS, et al. J Clin Pharm Ther. 2020 Feb;45(1):52-58. doi: 10.1111/jcpt.13062. Epub 2019 Oct 31. J Clin Pharm Ther. 2020. PMID: 31670842

7

Perspective on CYP2C19 genotyping test among patients with acute coronary syndrome - a qualitative study.

Png WY, Wong XY, Kwan YH, Lin YY, Tan DS. Png WY, et al. Among authors: tan ds. Future Cardiol. 2020 Nov;16(6):655-662. doi: 10.2217/fca-2020-0036. Epub 2020 Jun 11. Future Cardiol. 2020. PMID: 32524842

8

Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds.

Chang GS, Tan DS. Chang GS, et al. Among authors: tan ds. Eur Cardiol. 2020 Jun 29;15:e53. doi: 10.15420/ecr.2019.12. eCollection 2020 Feb. Eur Cardiol. 2020. PMID: 32684983 Free PMC article. Review.

9

Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations.

Narasimhalu K, Ang YK, Tan DSY, De Silva DA, Tan KB. Narasimhalu K, et al. Clin Drug Investig. 2020 Nov;40(11):1063-1070. doi: 10.1007/s40261-020-00970-y. Clin Drug Investig. 2020. PMID: 32959334

10

Cost-effectiveness of CYP2C19-guided antiplatelet therapy for acute coronary syndromes in Singapore.

Kim JH, Tan DS, Chan MYY. Kim JH, et al. Among authors: tan ds. Pharmacogenomics J. 2021 Apr;21(2):243-250. doi: 10.1038/s41397-020-00204-6. Epub 2021 Jan 18. Pharmacogenomics J. 2021. PMID: 33462345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

540 results

Search Page

Filters